Published in Methods Mol Biol on January 01, 2011
Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia | NCT00260338
Clinical Trials of Regeneration for Periodontal Tissue | NCT00221130
Implantable microenvironments to attract hematopoietic stem/cancer cells. Proc Natl Acad Sci U S A (2012) 1.44
Effect of Secreted Molecules of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells on Acute Hepatic Failure Model. Stem Cells Dev (2016) 0.77
Cell Injury-Induced Release of Fibroblast Growth Factor 2: Relevance to Intracerebral Mesenchymal Stromal Cell Transplantations. Stem Cells Dev (2015) 0.75
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med (1991) 16.81
Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood (2004) 13.79
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet (2004) 11.77
Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med (1999) 9.73
Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med (2008) 8.79
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol (2002) 6.92
Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res (2004) 6.49
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J (2006) 5.93
Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation (2003) 5.34
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation (2006) 5.33
Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med (2006) 4.53
Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood (2003) 4.09
From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol (2007) 3.87
Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci U S A (2007) 3.74
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant (2005) 2.82
Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One (2007) 2.80
Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol (2002) 2.72
Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology (2008) 2.50
Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells. J Clin Invest (1998) 2.20
Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int (2001) 2.06
Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span. J Clin Invest (2002) 1.43
Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med (2010) 7.11
Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science (2013) 3.26
Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One (2007) 2.80
Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng (2010) 2.66
Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology (2008) 2.50
Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant (2010) 2.50
Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology (2008) 2.45
A high-throughput microfluidic real-time gene expression living cell array. Lab Chip (2006) 1.93
Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure. Nat Biotechnol (2012) 1.74
Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo. Metab Eng (2009) 1.66
Self-assembling elastin-like peptides growth factor chimeric nanoparticles for the treatment of chronic wounds. Proc Natl Acad Sci U S A (2010) 1.63
Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation. Biophys J (2004) 1.61
Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells (2008) 1.58
Liver-specific functional studies in a microfluidic array of primary mammalian hepatocytes. Anal Chem (2006) 1.53
Three-dimensional primary hepatocyte culture in synthetic self-assembling peptide hydrogel. Tissue Eng Part A (2008) 1.52
Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun (2007) 1.52
Dynamic gene expression profiling using a microfabricated living cell array. Anal Chem (2004) 1.50
Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Mol Ther (2010) 1.47
Implantable microenvironments to attract hematopoietic stem/cancer cells. Proc Natl Acad Sci U S A (2012) 1.44
Integration of technologies for hepatic tissue engineering. Adv Biochem Eng Biotechnol (2007) 1.43
In vitro models of traumatic brain injury. Annu Rev Biomed Eng (2011) 1.38
Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes. Biophys Chem (2002) 1.38
A model for normothermic preservation of the rat liver. Tissue Eng (2007) 1.38
Nonthermal irreversible electroporation: fundamentals, applications, and challenges. IEEE Trans Biomed Eng (2013) 1.36
Homogeneous differentiation of hepatocyte-like cells from embryonic stem cells: applications for the treatment of liver failure. FASEB J (2007) 1.34
Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance. Proc Natl Acad Sci U S A (2009) 1.32
Recovery of warm ischemic rat liver grafts by normothermic extracorporeal perfusion. Transplantation (2009) 1.32
Tissue engineering and regenerative medicine: history, progress, and challenges. Annu Rev Chem Biomol Eng (2011) 1.31
Microfabrication-based modulation of embryonic stem cell differentiation. Lab Chip (2007) 1.27
Oxygen uptake rates and liver-specific functions of hepatocyte and 3T3 fibroblast co-cultures. Biotechnol Bioeng (2007) 1.24
Microfluidic flow-encoded switching for parallel control of dynamic cellular microenvironments. Lab Chip (2007) 1.23
DNA-triggered innate immune responses are propagated by gap junction communication. Proc Natl Acad Sci U S A (2009) 1.17
Designing a hepatocellular microenvironment with protein microarraying and poly(ethylene glycol) photolithography. Langmuir (2004) 1.17
Amphipathic peptide-based fusion peptides and immunoconjugates for the targeted ablation of prostate cancer cells. Cancer Res (2007) 1.16
Integrated energy and flux balance based multiobjective framework for large-scale metabolic networks. Ann Biomed Eng (2007) 1.15
Liver endothelial cells promote LDL-R expression and the uptake of HCV-like particles in primary rat and human hepatocytes. Hepatology (2006) 1.14
Optimization of reporter cells for expression profiling in a microfluidic device. Biomed Microdevices (2005) 1.10
A simplified subnormothermic machine perfusion system restores ischemically damaged liver grafts in a rat model of orthotopic liver transplantation. Transplant Res (2012) 1.10
Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model. Wound Repair Regen (2012) 1.10
A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats. J Surg Res (2006) 1.08
Thermodynamic and kinetic characterization of antisense oligodeoxynucleotide binding to a structured mRNA. Biophys J (2002) 1.08
Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha. PLoS One (2010) 1.07
Microfluidics and multielectrode array-compatible organotypic slice culture method. J Neurosci Methods (2008) 1.07
Subnormothermic machine perfusion at both 20°C and 30°C recovers ischemic rat livers for successful transplantation. J Surg Res (2011) 1.06
Cell delivery: from cell transplantation to organ engineering. Cell Transplant (2010) 1.06
Microfabricated grooved substrates as platforms for bioartificial liver reactors. Biotechnol Bioeng (2005) 1.05
Hepatic tissue engineering for adjunct and temporary liver support: critical technologies. Liver Transpl (2004) 1.04
The fabrication of low-impedance nanoporous gold multiple-electrode arrays for neural electrophysiology studies. Nanotechnology (2010) 1.04
Ultrasensitive detection of low-abundance surface-marker protein using isothermal rolling circle amplification in a microfluidic nanoliter platform. Small (2010) 1.03
Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burn. Cell Transplant (2010) 1.03
Vitrification by ultra-fast cooling at a low concentration of cryoprotectants in a quartz micro-capillary: a study using murine embryonic stem cells. Cryobiology (2008) 1.02
Identification of optimal classification functions for biological sample and state discrimination from metabolic profiling data. Bioinformatics (2004) 1.00
Polyelectrolyte nano-scaffolds for the design of layered cellular architectures. Tissue Eng (2006) 1.00
Non-thermal, pulsed electric field cell ablation: A novel tool for regenerative medicine and scarless skin regeneration. Technology (Singap World Sci) (2013) 0.99
A microfluidic hepatic coculture platform for cell-based drug metabolism studies. Biochem Pharmacol (2009) 0.99
Building and manipulating neural pathways with microfluidics. Lab Chip (2010) 0.99
Metabolic flux analysis of cultured hepatocytes exposed to plasma. Biotechnol Bioeng (2003) 0.99
Steatosis reversibly increases hepatocyte sensitivity to hypoxia-reoxygenation injury. J Surg Res (2008) 0.98
Application of multivariate analysis to optimize function of cultured hepatocytes. Biotechnol Prog (2003) 0.98
The use of elastin-like polypeptide-polyelectrolyte complexes to control hepatocyte morphology and function in vitro. Biomaterials (2007) 0.98
Profiling of dynamic changes in hypermetabolic livers. Biotechnol Bioeng (2003) 0.98
Identification of neutrophil gelatinase-associated lipocalin (NGAL) as a discriminatory marker of the hepatocyte-secreted protein response to IL-1beta: a proteomic analysis. Biotechnol Bioeng (2005) 0.98
Bioengineering of liver assist devices. J Hepatobiliary Pancreat Surg (2002) 0.98
Patterned co-culture of primary hepatocytes and fibroblasts using polyelectrolyte multilayer templates. Macromol Biosci (2007) 0.97
Treatment of fulminant hepatic failure in rats using a bioartificial liver device containing porcine hepatocytes producing interleukin-1 receptor antagonist. Tissue Eng (2006) 0.97
Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism. J Hepatol (2011) 0.97
Contribution of gene expression to metabolic fluxes in hypermetabolic livers induced through burn injury and cecal ligation and puncture in rats. Biotechnol Bioeng (2007) 0.97
Metabolic flux analysis of hepatocyte function in hormone- and amino acid-supplemented plasma. Metab Eng (2003) 0.97
Nest making and oxytocin comparably promote wound healing in isolation reared rats. PLoS One (2009) 0.97
Influence of insulin therapy on burn wound healing in rats. J Surg Res (2003) 0.97
Excorporeal normothermic machine perfusion resuscitates pig DCD livers with extended warm ischemia. J Surg Res (2011) 0.97
A novel formulation of oxygen-carrying matrix enhances liver-specific function of cultured hepatocytes. FASEB J (2006) 0.96
In situ metabolic flux analysis to quantify the liver metabolic response to experimental burn injury. Biotechnol Bioeng (2010) 0.96
Bioinformatics analysis of the early inflammatory response in a rat thermal injury model. BMC Bioinformatics (2007) 0.96
Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure. Tissue Eng Part A (2009) 0.95
Droplet-based microfluidic platforms for single T cell secretion analysis of IL-10 cytokine. Biosens Bioelectron (2010) 0.95
Effects of dehydroepiandrosterone administration on rat hepatic metabolism following thermal injury. J Surg Res (2005) 0.95
Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b+ splenocytes. Gastroenterology (2010) 0.94
Technique for expanding the donor liver pool: heat shock preconditioning in a rat fatty liver model. Liver Transpl (2004) 0.94
A microfluidic bioreactor for increased active retrovirus output. Lab Chip (2007) 0.94
Control analysis of mitochondrial metabolism in intact hepatocytes: effect of interleukin-1beta and interleukin-6. Metab Eng (2003) 0.94
A new technique for primary hepatocyte expansion in vitro. Biotechnol Bioeng (2008) 0.93
Engineering of an hepatic organoid to develop liver assist devices. Cell Transplant (2010) 0.93
Cell-cell interaction modulates neuroectodermal specification of embryonic stem cells. Neurosci Lett (2008) 0.93
Modulation of single-chain antibody affinity with temperature-responsive elastin-like polypeptide linkers. Biomacromolecules (2006) 0.92
Evolution of intrahepatic carbon, nitrogen, and energy metabolism in a D-galactosamine-induced rat liver failure model. Metab Eng (2005) 0.92
Dynamic interplay of flow and collagen stabilizes primary hepatocytes culture in a microfluidic platform. Lab Chip (2014) 0.91
Supercooling as a viable non-freezing cell preservation method of rat hepatocytes. PLoS One (2013) 0.91
Amino acid-mediated heterotypic interaction governs performance of a hepatic tissue model. FASEB J (2009) 0.91
A novel ultrathin collagen nanolayer assembly for 3-D microtissue engineering: Layer-by-layer collagen deposition for long-term stable microfluidic hepatocyte culture. Technology (Singap World Sci) (2014) 0.90
Efficacy of an extracorporeal flat-plate bioartificial liver in treating fulminant hepatic failure. J Surg Res (2003) 0.90